TCF3

TCF3

Target · Transcription factor

TCF3 Transcription factor 3 · Transcription factor E2-alpha

TCF3 (transcription factor 3, also known as E2A, E47, ITF1, VDIR and p75) is a class I basic helix-loop-helix transcription factor of the E protein family. It binds E-box sequences to regulate gene expression and is required for B and T lymphocyte development. Browse Assay Genie's current range of TCF3 research reagents below, or read on for the biology behind the target.

Nuclear proteinClass I E protein bHLHRequired for lymphopoiesis
654 aa
Protein length
~68 kDa
Molecular weight
19p13.3
Gene locus
bHLH E protein
Protein family
Target information

What is TCF3 (transcription factor 3)?

TCF3 is a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding regulatory E-box sequences on target genes, acting as either heterodimers or homodimers. Their activity is inhibited by heterodimerisation with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. UniProt also records that TCF3 facilitates ATOH7 binding to DNA at the consensus sequence 5'-CAGGTG-3' and positively regulates its transcriptional activity.

The TCF3 gene encodes transcription factor E2-alpha, a nuclear protein assigned by HGNC to the basic helix-loop-helix group. The gene is also known by the aliases E2A, ITF1, bHLHb21, VDIR, E47 and p75, and orthologues are present in mouse and rat (both Tcf3). Alternatively spliced transcript variants encoding multiple isoforms have been observed, and a pseudogene of the gene lies on the short arm of chromosome 9.

TCF3 plays a critical role in lymphopoiesis and is required for B and T lymphocyte development. Deletion of the gene, or diminished activity of the encoded protein, may contribute to lymphoid malignancies. The gene is also involved in several chromosomal translocations associated with leukaemia: t(1;19) with PBX1 in pre-B-cell acute lymphoblastic leukaemia, t(19;19) with TFPT in childhood leukaemia, and t(12;19) with ZNF384 in acute leukaemia. These features make TCF3 a frequent subject in studies of lymphocyte differentiation and leukaemia biology.

Lymphocyte development

TCF3 is required for B and T lymphocyte development, making it a central factor in studies of lymphopoiesis.

Leukaemia and lymphoid malignancy

TCF3 translocations with PBX1, TFPT and ZNF384 are associated with lymphoid leukaemias, and reduced TCF3 activity may contribute to lymphoid malignancy.

E-box transcriptional regulation

E proteins bind E-box sequences as homodimers or heterodimers to activate target genes, a mechanism studied through TCF3.

bHLH dimerisation and inhibition

E protein activity is inhibited by heterodimerisation with class IV inhibitor of DNA-binding proteins, offering a model of bHLH regulation.

Background

TCF3 frequently asked questions

What does TCF3 do?

TCF3 is a class I helix-loop-helix transcription factor that activates transcription by binding E-box sequences as a homodimer or heterodimer. It is required for B and T lymphocyte development, and it facilitates ATOH7 binding to the DNA sequence 5'-CAGGTG-3'.

What other names does TCF3 go by, and does it have isoforms?

TCF3 is also called E2A, ITF1, bHLHb21, VDIR, E47 and p75, and its UniProt name is transcription factor E2-alpha. Alternatively spliced transcript variants encoding multiple isoforms have been observed, so check which isoform a reagent recognises.

Is TCF3 linked to disease or conserved in other species?

TCF3 is involved in chromosomal translocations associated with lymphoid malignancies, including fusions with PBX1, TFPT and ZNF384. Orthologues exist in mouse and rat (Tcf3). Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other TCF-named transcription factors that may be of interest alongside TCF3 in transcriptional regulation research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P15923; product specifications from Assay Genie datasheets.

TCF3 Product listing